Essity AB Series B (0RQD)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 275.75 |
|---|---|
| 52-week range | 233.48 – 285.35 |
| Return, 1 month / 3 months | +5.4% / −0.9% |
| Return, 1 year / 3 years | +12.1% / +28.6% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 18.8% |
| Worst drawdown (1 year) | -14.7% |
| Average daily value traded | 98.56M SEK |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Essity is a hygiene and health company based in Sweden. It makes consumer tissue products such as toilet paper, paper towels and napkins, and supplies professional tissue and hygiene systems to businesses and institutions under brands including Tork. It also produces personal care products, among them incontinence products, baby diapers and feminine hygiene items, sold through retailers and healthcare channels in many countries.
Essity AB Series B trades under the code 0RQD on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Essity AB Series B (0RQD) trades on the London Exchange in UK. It last closed at SEK 275.75 on 19 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 374 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.1% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.0% | ||
| From 52-week high | -3.0% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | 10.8% | ||
| 12-month return, skipping the last month | 6.4% | ||
| Risk (lower is better) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 18.8% | ||
| Worst drawdown (1 year) | -14.7% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 98.56M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | +5.4% |
| 3 months | −0.9% |
| 6 months | +10.8% |
| 1 year | +12.1% |
| 3 years | +28.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 268.81 / 262.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | SEK 8.7500 |
| 28 Mar 2025 | SEK 8.2500 |
| 22 Mar 2024 | SEK 7.7500 |
| 30 Mar 2023 | SEK 7.2500 |
| 25 Mar 2022 | SEK 7.0000 |
| 26 Mar 2021 | SEK 6.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.